跳至主要内容
欧盟官方标签名称词汇表条目 8675

DIHYDROCOUMARIN

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 9 个有匹配的监管证据:9 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

9 个市场有证据
已检查的市场
13
有证据的市场
9
证据缺口
4
已解析的标识符
2

已解析的物质身份

CAS:119-84-6
EC:204-354-9
成分索引记录:
DIHYDROCOUMARIN
化妆品功能: FRAGRANCE, PERFUMING

清单限制备注: II/427

8 个匹配或报告的名称
DIHYDROCOUMARIN3,4-Dihydrocoumarin, when used as a fragrance ingredientDihydrocoumarinDihydrocoumarin, when used as a fragrance ingredient.3,4-二氢香豆素 — 3,4-Dihydrocoumarine (CAS No. 119-84-6)디하이드로쿠마린Dihidrocumarina, quando usado como ingrediente de fragrância.3,4-Dihydrocoumarin (CAS No. 119-84-6), when used as a fragrance ingredient.

全部 13 个市场的监管证据

打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。

滑动或横向滚动以查看数据集覆盖范围和后续操作。

市场结果记录数据集含义 / 后续操作
European Union
EU
未找到匹配项0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
Prohibited1打开记录 1
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
请查看每条关联记录及其确切条件。
Canada
CA
Restricted1打开记录 1
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
请查看每条关联记录及其确切条件。
New Zealand
NZ
Prohibited1打开记录 1
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
请查看每条关联记录及其确切条件。
ASEAN
ASEAN
Prohibited1打开记录 1
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
请查看每条关联记录及其确切条件。
China
CN
Prohibited1打开记录 1
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
请查看每条关联记录及其确切条件。
Japan
JP
未找到匹配项0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Prohibited1打开记录 1
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
请查看每条关联记录及其确切条件。
United States
US
未找到匹配项0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
未找到匹配项0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
Prohibited1打开记录 1
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
请查看每条关联记录及其确切条件。
India
IN
Prohibited1打开记录 1
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
请查看每条关联记录及其确切条件。
Saudi Arabia
SA
Prohibited1打开记录 1
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
请查看每条关联记录及其确切条件。
没有与此筛选条件匹配的市场行。

匹配的市场记录和条件

化学身份与性质

CAS 119-84-6 的 PubChem 二维化学结构
CAS 119-84-6PubChem CID 660

Dihydrocoumarin

3,4-dihydrocoumarin is a chromanone that is the 3,4-dihydro derivative of coumarin. It has a role as a plant metabolite. It is functionally related to a coumarin. — ChEBI

IUPAC 名称
3,4-dihydrochromen-2-one
分子式
C9H8O2
分子量
148.16 g/mol
精确质量
148.052429494 Da
XLogP3
1.6
拓扑极性表面积
26.3 Ų
氢键供体
0
氢键受体
2
共价单元
1
已定义的立体中心
0

又称

3,4-dihydrocoumarinhydrocoumarinBenzodihydropyronemelilotin2-chromanone1,2-benzodihydropyronemelilotic lactoneMelilotine
另有 16 个已报告名称
Oxochroman2H-1-Benzopyran-2-one, 3,4-dihydro-Chroman, 2-oxo-DihydrobenzopyroneUsaf do-12Coumarin, 3,4-dihydro-Meliotine2-Hydroxydihydrocinnamic acid lactoneNCI-C55890o-hydroxydihydrocinnamic acid lactoneFEMA No. 2381Hydrocinnamic acid, o-hydroxy-, delta-lactoneNM5K1Y1BT2CHEBI:16151NSC-10121RefChem:91117
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配660

Attributed physical-property, hazard, environmental and use annotations.

  • Substance: 3,4-Dihydrocoumarin 来源: NTP Technical Reports
  • NTP Technical Report: TR-423: Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CASRN 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies) (1993 ) 来源: NTP Technical Reports
  • Peer Review Date: 06/23/92 来源: NTP Technical Reports
  • Conclusion for Male Rat: Some Evidence 来源: NTP Technical Reports
  • Conclusion for Female Rat: No Evidence 来源: NTP Technical Reports
  • Conclusion for Male Mice: No Evidence 来源: NTP Technical Reports
  • Conclusion for Female Mice: Some Evidence 来源: NTP Technical Reports
  • Summary: Under the conditions of these 2-year gavage studies, there was some evidence of carcinogenic activity of 3,4-dihydrocoumarin in male F344/N rats based on increased incidences of renal tubule adenomas and focal hyperplasia. The transitional cell carcinomas in two 600 mg/kg males may also have been chemical related. There was no evidence of carcinogenic activity of 3,4-dihydrocoumarin in female F344/N rats receiving 150, 300, or 600 mg/kg. There was no evidence of carcinogenic activity of 3,4-dihydrocoumarin in male B6C3F1 mice receiving 200, 400, or 800 mg/kg. There was some evidence of carcinogenic activity in female B6C3F1 mice based on increased incidences of hepatocellular adenoma and hepatocellular adenoma or carcinoma (combined).; 3,4-Dihydrocoumarin caused ulcers, hyperplasia, and inflammation of the forestomach, parathyroid gland hyperplasia, and increased severity of nephropathy in male rats. 来源: NTP Technical Reports
  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou 来源: CAMEO Chemicals
  • Signal: Warning 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (> 99.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H317 (97.4%): May cause an allergic skin reaction [Warning Sensitization, Skin] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1702 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Signal: Warning 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
  • Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定